Article Information
History
- July 19, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Fiona FJ Ng1,
- Rashmi Verma1,
- Levana Sani1,
- Astrid Irwanto1,
- Michael Lee2,
- Angeline Wee2,
- Shih Kiat Chng2,
- Melvyn Wong2 and
- Alexandre Chan3,*
- 1NalaGenetics Pte Ltd (NalaGenetics), Singapore, Singapore
- 2Raffles Medical Group, Singapore, Singapore
- 3University of California, Irvine, School of Pharmacy & Pharmaceutical Sciences, Irvine, USA
- ↵*Corresponding Author Email: a.chan{at}uci.edu (AC)
Posted July 19, 2024.
Implementation of Pre-emptive Pharmacogenomics Testing in Outpatient Clinics in Asia (IMPT study)
